As of July 2022 Neurocrine Biosciences has a market cap of $9.48 Billion. This makes Neurocrine Biosciences the world's 1434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $9.48 B | 17.4% |
2021 | $8.07 B | -9.78% |
2020 | $8.95 B | -9.71% |
2019 | $9.91 B | 52.97% |
2018 | $6.48 B | -5.57% |
2017 | $6.86 B | 104.23% |
2016 | $3.36 B | -31.11% |
2015 | $4.87 B | 185.67% |
2014 | $1.70 B | 171.56% |
2013 | $0.62 B | 26.57% |
2012 | $0.49 B | 5.82% |
2011 | $0.46 B | 12.02% |
2010 | $0.41 B | 250.42% |
2009 | $0.11 B | -3.12% |
2008 | $0.12 B | -28.92% |
2007 | $0.17 B | -56.01% |
2006 | $0.39 B | -83.04% |
2005 | $2.32 B | 29.33% |
2004 | $1.80 B | -6.48% |
2003 | $1.92 B | 37.56% |
2002 | $1.40 B | -10.09% |
2001 | $1.55 B |
On Jul 1st, 2022 the market cap of Neurocrine Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $293.50 B | 2,994.10% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $271.78 B | 2,765.08% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $308.52 B | 3,152.44% | ๐บ๐ธ USA |
![]() Repligen
RGEN | $9.23 B | -2.69% | ๐บ๐ธ USA |
![]() Athersys ATHX | $0.06 B | -99.33% | ๐บ๐ธ USA |
![]() ANI Pharmaceuticals ANIP | $0.54 B | -94.27% | ๐บ๐ธ USA |
![]() Palatin Technologies PTN | $0.06 B | -99.33% | ๐บ๐ธ USA |
![]() Royalty Pharma RPRX | $28.84 B | 204.11% | ๐ฌ๐ง UK |